Umeå University's logo

umu.sePublications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Staphylococcus aureus susceptibility to complestatin and corbomycin depends on the VraSR two-component system
Laboratory of Microbial Pathogenesis, Navarrabiomed, Hospital Universitario de Navarra (HUN), Universidad Pública de Navarra (UPNA), IdiSNA, Pamplona, Spain.
Umeå University, Faculty of Medicine, Molecular Infection Medicine Sweden (MIMS). Umeå University, Faculty of Medicine, Umeå Centre for Microbial Research (UCMR). Umeå University, Faculty of Medicine, Department of Molecular Biology (Faculty of Medicine).ORCID iD: 0000-0002-8349-360x
Department of Biochemistry and Biomedical Sciences, M. G. DeGroote Institute for Infectious Disease Research, David Braley Centre for Antibiotic Discovery, McMaster University, ON, Hamilton, Canada.
Department of Biochemistry and Biomedical Sciences, M. G. DeGroote Institute for Infectious Disease Research, David Braley Centre for Antibiotic Discovery, McMaster University, ON, Hamilton, Canada.
Show others and affiliations
2023 (English)In: Microbiology Spectrum, E-ISSN 2165-0497, Vol. 11, no 5, article id e0037023Article in journal (Refereed) Published
Abstract [en]

The overuse of antibiotics in humans and livestock has driven the emergence and spread of antimicrobial resistance and has therefore prompted research on the discovery of novel antibiotics. Complestatin (Cm) and corbomycin (Cb) are glycopeptide antibiotics with an unprecedented mechanism of action that is active even against methicillin-resistant and daptomycin-resistant Staphylococcus aureus. They bind to peptidoglycan and block the activity of peptidoglycan hydrolases required for remodeling the cell wall during growth. Bacterial signaling through two-component transduction systems (TCSs) has been associated with the development of S. aureus antimicrobial resistance. However, the role of TCSs in S. aureus susceptibility to Cm and Cb has not been previously addressed. In this study, we determined that, among all 16 S. aureus TCSs, VraSR is the only one controlling the susceptibility to Cm and Cb. Deletion of vraSR increased bacterial susceptibility to both antibiotics. Epistasis analysis with members of the vraSR regulon revealed that deletion of spdC, which encodes a membrane protein that scaffolds SagB for cleavage of peptidoglycan strands to achieve physiological length, in the vraSR mutant restored Cm and Cb susceptibility to wild-type levels. Moreover, deletion of either spdC or sagB in the wild-type strain increased resistance to both antibiotics. Further analyses revealed a significant rise in the relative amount of peptidoglycan and its total degree of cross-linkage in ΔspdC and ΔsagB mutants compared to the wild-type strain, suggesting that these changes in the cell wall provide resistance to the damaging effect of Cm and Cb. IMPORTANCE Although Staphylococcus aureus is a common colonizer of the skin and digestive tract of humans and many animals, it is also a versatile pathogen responsible for causing a wide variety and number of infections. Treatment of these infections requires the bacteria to be constantly exposed to antibiotic treatment, which facilitates the selection of antibiotic-resistant strains. The development of new antibiotics is, therefore, urgently needed. In this paper, we investigated the role of the sensory system of S. aureus in susceptibility to two new antibiotics: corbomycin and complestatin. The results shed light on the cell-wall synthesis processes that are affected by the presence of the antibiotic and the sensory system responsible for coordinating their activity.

Place, publisher, year, edition, pages
American Society for Microbiology, 2023. Vol. 11, no 5, article id e0037023
Keywords [en]
autolysins, complestatin, corbomycin, Staphylococcus aureus, two-component system, VraSR
National Category
Microbiology in the medical area Microbiology
Identifiers
URN: urn:nbn:se:umu:diva-216644DOI: 10.1128/spectrum.00370-23ISI: 001413726300001PubMedID: 37646518Scopus ID: 2-s2.0-85175571323OAI: oai:DiVA.org:umu-216644DiVA, id: diva2:1815420
Funder
Knut and Alice Wallenberg FoundationAvailable from: 2023-11-28 Created: 2023-11-28 Last updated: 2025-04-28Bibliographically approved

Open Access in DiVA

fulltext(977 kB)110 downloads
File information
File name FULLTEXT01.pdfFile size 977 kBChecksum SHA-512
8192e2e9b13139c3865e1760d5b185ce66f623a2d7e2559889cd41dd99312eb1d60733d87deb92bd963561f05391914d59b15e9f5d2cf2d500dbf547bdcc812a
Type fulltextMimetype application/pdf

Other links

Publisher's full textPubMedScopus

Authority records

Hernandez, Sara B.Cava, Felipe

Search in DiVA

By author/editor
Hernandez, Sara B.Cava, Felipe
By organisation
Molecular Infection Medicine Sweden (MIMS)Umeå Centre for Microbial Research (UCMR)Department of Molecular Biology (Faculty of Medicine)
In the same journal
Microbiology Spectrum
Microbiology in the medical areaMicrobiology

Search outside of DiVA

GoogleGoogle Scholar
Total: 110 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 185 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf